An OLIP Study (Open Label Individual Patient) of Nusinersen in a Participant With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen (clinicaltrials.gov) - Sep 25, 2026 - P=N/A | N=1 | Not yet recruiting | Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
New trial • Genetic Disorders • Movement Disorders • Muscular Atrophy • Rare Diseases
|